Hepatocellular Carcinoma: Hepatic Resection Versus Transplantation
From 1980 to 1989,76 patients with hepatocellular carcinoma were treated by subtotal hepatic resection (HX) and 105 by orthotopic liver transplantation (TX). The overall 1 to 5 year survival rates of the HX group were 71.1%, 55.0%, 47.2%, 37.2% and 32.9% respectively, and those of the TX group were 65.7%, 49.0%, 39.2%, 35.6% and 35.6%, respectively. The survival was similar stage by stage in both groups and correlated well with the pTNM classification. Tumor recurrence was high in both groups after HX (50%) and TX (43%) particularly in stages IV-A (≥ 60%). Twelve patients after HX and 13 patients after TX lived more than 5 years.
KeywordsTNM classification and hepatocellular carcinoma
Unable to display preview. Download preview PDF.
- 6.Iwatsuki S, Starzl TE, Sheahan MB, Yokoyama H, Demetris AJ, Todo S, Tzakis AG, Van Thiel DH, Carr B, Selby R and Madariaga J. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg, 1991; 221–223.Google Scholar
- 7.American Joint Committee on Cancer. Manual for Staging of Cancer, 3rd Edition. Philadelphia: JB Lippincott, 1987, pp 87–92.Google Scholar